Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Vehreschild

Showing results (71-80 of 221) with videos related to

Pageof 23
Sort By:
The Lancet. Infectious Diseases|February 2, 2023
Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysisRoel P J Willems, Karin van Dijk, Maria J G T Vehreschild, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 21, 2021
Clinical effectiveness of bidirectional fecal microbiota transfer in the treatment of recurrent Clostridioides difficile infectionsChristian Bestfater, Maria J G T Vehreschild, Andreas Stallmach, et al.
Critical Reviews in Microbiology|August 25, 2012
Mucormycosis treated with posaconazole: review of 96 case reportsJoerg J Vehreschild, Andrea Birtel, Maria J G T Vehreschild, et al.
Mycoses|December 23, 2020
Clinical and pharmacoeconomic evaluation of antifungal prophylaxis with continuous micafungin in patients undergoing allogeneic stem cell transplantation: A six-year cohort analysisSebastian M Wingen-Heimann, Oliver A Cornely, Maria J G T Vehreschild, et al.
Infectious Diseases and Therapy|October 15, 2022
Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 TrialMaria J G T Vehreschild, Petar Atanasov, Kateryna Yurko, et al.
Frontiers in Medicine|November 7, 2025
Effect of thyme-ivy syrup on antiviral immune response in patients with mild COVID-19: a prospective, open-label, randomized pilot studyStephanie Dauth, Stephan M G Schäfer, Maximilian Klippstein, et al.
Bone Marrow Transplantation|November 14, 2017
Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantationF Farowski, V Bücker, J J Vehreschild, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Clostridium difficile infection in patients with acute myelogenous leukemia and in patients undergoing allogeneic stem cell transplantation: epidemiology and risk factor analysisMaria J G T Vehreschild, David Weitershagen, Lena M Biehl, et al.
Digestion|November 14, 2018
An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia MuciniphilaRebeca M Cruz-Aguliar, Nina Wantia, Thomas Clavel, et al.
Viruses|May 28, 2022
Longitudinal Analysis of Coronavirus-Neutralizing Activity in COVID-19 PatientsFlorian D Hastert, Lisa Henss, Christine von Rhein, et al.
Pageof 23

Showing results (71-80 of 221) with videos related to

Sort By:
Pageof 23
The Lancet. Infectious Diseases|February 2, 2023
Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysisRoel P J Willems, Karin van Dijk, Maria J G T Vehreschild, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 21, 2021
Clinical effectiveness of bidirectional fecal microbiota transfer in the treatment of recurrent Clostridioides difficile infectionsChristian Bestfater, Maria J G T Vehreschild, Andreas Stallmach, et al.
Critical Reviews in Microbiology|August 25, 2012
Mucormycosis treated with posaconazole: review of 96 case reportsJoerg J Vehreschild, Andrea Birtel, Maria J G T Vehreschild, et al.
Mycoses|December 23, 2020
Clinical and pharmacoeconomic evaluation of antifungal prophylaxis with continuous micafungin in patients undergoing allogeneic stem cell transplantation: A six-year cohort analysisSebastian M Wingen-Heimann, Oliver A Cornely, Maria J G T Vehreschild, et al.
Infectious Diseases and Therapy|October 15, 2022
Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 TrialMaria J G T Vehreschild, Petar Atanasov, Kateryna Yurko, et al.
Frontiers in Medicine|November 7, 2025
Effect of thyme-ivy syrup on antiviral immune response in patients with mild COVID-19: a prospective, open-label, randomized pilot studyStephanie Dauth, Stephan M G Schäfer, Maximilian Klippstein, et al.
Bone Marrow Transplantation|November 14, 2017
Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantationF Farowski, V Bücker, J J Vehreschild, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Clostridium difficile infection in patients with acute myelogenous leukemia and in patients undergoing allogeneic stem cell transplantation: epidemiology and risk factor analysisMaria J G T Vehreschild, David Weitershagen, Lena M Biehl, et al.
Digestion|November 14, 2018
An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia MuciniphilaRebeca M Cruz-Aguliar, Nina Wantia, Thomas Clavel, et al.
Viruses|May 28, 2022
Longitudinal Analysis of Coronavirus-Neutralizing Activity in COVID-19 PatientsFlorian D Hastert, Lisa Henss, Christine von Rhein, et al.
Pageof 23